Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multiresistant tuberculosis]

J F Murray1

  • 1Pulmonary and Critical Care Division, San Francisco General Hospital Medical Center, University of California San Francisco.

Revue De Pneumologie Clinique
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Melanin-concentrating hormone in peripheral circulation in the human.

The Journal of endocrinology·2017
Same author

Assessing Heterogeneity of Treatment Effect Using Real World Data.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

The Industrial Revolution and the decline in death rates from tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2015
Same author

Classification of polycythemic disorders with comments of the diagnostic value of arterial blood oxygen analysis.

Annals of internal medicine·2013
Same author

Pulmonary edema: pathophysiology and diagnosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2011
Same author

Vole bacillus; susceptibility of South African wild rodents to the vole strain of acid-fast bacillus and to other acid-fast bacilli; preliminary report.

American review of tuberculosis·2010
Same journal

[Respiratory Medicine and Research: The new SPLF's anglophone journal].

Revue de pneumologie clinique·2018
Same journal

[Medical journals publication: Let's change].

Revue de pneumologie clinique·2018
Same journal

[Multiple ulcerated tracheobronchial mucosal lesions in the eosinophilic granulomatosis with polyangiitis].

Revue de pneumologie clinique·2018
Same journal

[Medium and long-term respiratory outcome in patients operated from congenital diaphragmatic hernia: From a series of 56 patients].

Revue de pneumologie clinique·2018
Same journal

[Sporadic lymphangioleiomyomatosis: A rare cause of bilateral spontaneous pneumothorax in young woman].

Revue de pneumologie clinique·2018
Same journal

[COPD and smoking cessation: Patients' expectations and responses of health professionals].

Revue de pneumologie clinique·2018
See all related articles

Multiresistant tuberculosis, especially strains resistant to isoniazid and rifampicin, poses a global health crisis, particularly for HIV patients. New drugs and improved prevention are crucial to combat this escalating challenge.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Context:

  • Multiresistant tuberculosis strains, resistant to isoniazid and rifampicin, are spreading rapidly.
  • Severe tuberculosis disease is developing in HIV-infected patients.
  • Controlling tuberculosis is increasingly difficult globally, especially in developing nations.

Purpose:

  • To highlight the growing problem of multidrug-resistant tuberculosis (MDR-TB).
  • To emphasize the need for new antituberculosis drugs and improved prevention strategies.
  • To underscore the importance of surveillance and proper treatment protocols.

Summary:

  • Multiresistant tuberculosis strains, resistant to key drugs like isoniazid and rifampicin, present a severe global health threat.
  • The rapid spread of these resistant strains, coupled with high rates of HIV infection, exacerbates the crisis, particularly in Southeast Asia and Sub-Saharan Africa.

Related Experiment Videos

  • Effective control requires new antituberculosis drugs, enhanced prevention, and improved treatment adherence, including clinician adherence to prescribing multiple active drugs and patient compliance.

    • Impact:

    • Urgent development of new antituberculosis drugs is needed.
    • Improved prevention strategies are essential to curb the spread of resistant strains.
    • Enhanced global surveillance and adherence to treatment protocols are critical for managing MDR-TB.